US FDA approves AstraZeneca’s bladder cancer drug

Short resume:

astrazeneca
90%
drug
80%
linkedin
80%
twitter
80%

The U.S. Food and Drug Administration on Monday granted accelerated approval to AstraZeneca Plc’s immuno-oncology drug to treat a type of bladder cancer in patients whose disease progressed following chemotherapy.
Source Channel NewsAsia
Read More…

More News

Be the first to comment

Leave a Reply

Your email address will not be published.


*